Standard BioTools Inc. (LAB)

NMS – Real Time Price. Currency in USD

0.79

-0.00 (-0.32%)

Market open: Aug 12, 2026, 11:43 AM EDT

0.78

-0.01 (-0.95%)

Previous after-hours: Aug 11, 2026, 7:23 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

85M

91M

106M

98M

Cost of goods sold

-43M

-46M

-56M

-61M

Gross Profit

43M

45M

50M

37M

Operating expenses (excl. COGS)

-136M

-132M

-113M

-150M

Operating Income

-93M

-87M

-63M

-113M

Non-operating income, total

-3M

-11M

-80M

Pretax income

-97M

-90M

-74M

-193M

Equity in earnings

Taxes

38M

-542K

-452K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-59M

-91M

-75M

-190M

Discontinued operations

-16M

-48M

Net income

-75M

-139M

-75M

-190M

Dilution adjustment

Preferred dividends

46M

Standard BioTools Inc. (LAB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Standard BioTools Inc. (LAB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Standard BioTools Inc. (LAB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Standard BioTools Inc. (LAB)

Income Statement (Annual)

Income Statement (Annual)